Exploring Breakthroughs in Alzheimer's Treatment with Dr. Missling, CEO of Anavex Corp.
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
-
Narrado por:
-
De:
Send us a text
Exploring Alzheimer's Treatment and Prevention with Dr. Christopher Missling
In this episode of Open Forum in The Villages, host Mike Roth interviews Dr. Christopher Missling, President and CEO of Anavex Life Sciences. They discuss Dr. Missling's work in developing potential treatments for degenerative diseases like Alzheimer's and Parkinson's. The conversation covers the concept of precision medicine, the current landscape of Alzheimer's treatment, and the promising drug blarcamesine, which aims to restore autophagy and regenerate neural cells. Dr. Missling shares insights into the challenges of treating Alzheimer's, the stages of their drug's approval process, and the importance of early and ongoing intervention. The episode highlights the need for a preventive approach to maintain brain health and the potential benefits of lifestyle changes like diet and exercise.
00:00 Introduction to Open Forum in The Villages
00:34 Meet Dr. Christopher Missling: President and CEO of Avavex Life Sciences
01:38 Understanding Precision Medicine
02:26 The Current Landscape of Alzheimer's Disease
05:00 Introducing Blarcamesine: A Potential Alzheimer's Treatment
10:26 The Importance of Early Treatment and Prevention
12:45 Lifestyle Tips for Prolonging Brain Health
16:47 Conclusion and Listener Engagement
Support the show
Open Forum in The Villages, Florida is Produced & Directed by Mike Roth
A new episode will be released most Fridays at 9 AM
Direct all questions and comments to mike@rothvoice.com
If you know a Villager who should appear on the show, please contact us at: mike@rothvoice.com